4.7 Article

Transcription factor old astrocyte specifically induced substance is a novel regulator of kidney fibrosis

Journal

FASEB JOURNAL
Volume 35, Issue 2, Pages -

Publisher

WILEY
DOI: 10.1096/fj.202001820R

Keywords

chronic kidney disease; fibrosis; myofibroblast; transcription regulation

Funding

  1. MEXT \ Japan Society for the Promotion of Science (JSPS) [18K15027, 18H02603, 18K19545]
  2. HHS \ National Institutes of Health (NIH) [R01 HL148165]
  3. Takeda Science Foundation
  4. Japanese Association of Dialysis Physicians (JAPD)
  5. Japan Agency for Medical Research and Development (AMED) [JP20am0101084]
  6. Grants-in-Aid for Scientific Research [18K19545, 18K15027, 18H02603] Funding Source: KAKEN

Ask authors/readers for more resources

The study identified that OASIS in myofibroblasts promotes kidney fibrosis, partially through increased Bst2 expression. Systemic genetic knockout of OASIS reduces myofibroblast proliferation and systemic anti-Bst2 blocking antibody approach attenuates kidney fibrosis in normal mice after UUO.
Prevention of kidney fibrosis is an essential requisite for effective therapy in preventing chronic kidney disease (CKD). Here, we identify Old astrocyte specifically induced substance (OASIS)/cAMP responsive element-binding protein 3-like 1 (CREB3l1), a CREB/ATF family transcription factor, as a candidate profibrotic gene that drives the final common pathological step along the fibrotic pathway in CKD. Although microarray data from diseased patient kidneys and fibrotic mouse model kidneys both exhibit OASIS/Creb3l1 upregulation, the pathophysiological roles of OASIS in CKD remains unknown. Immunohistochemistry revealed that OASIS protein was overexpressed in human fibrotic kidney compared with normal kidney. Moreover, OASIS was upregulated in murine fibrotic kidneys, following unilateral ureteral obstruction (UUO), resulting in an increase in the number of OASIS-expressing pathological myofibroblasts. In vitro assays revealed exogenous TGF-beta 1 increased OASIS expression coincident with fibroblast-to-myofibroblast transition and OASIS contributed to TGF-beta 1-mediated myofibroblast migration and increased proliferation. Significantly, in vivo kidney fibrosis induced via UUO or ischemia/reperfusion injury was ameliorated by systemic genetic knockout of OASIS, accompanied by reduced myofibroblast proliferation. Microarrays revealed that the transmembrane glycoprotein Bone marrow stromal antigen 2 (Bst2) expression was reduced in OASIS knockout myofibroblasts. Interestingly, a systemic anti-Bst2 blocking antibody approach attenuated kidney fibrosis in normal mice but not in OASIS knockout mice after UUO, signifying Bst2 functions downstream of OASIS. Finally, myofibroblast-restricted OASIS conditional knockouts resulted in resistance to kidney fibrosis. Taken together, OASIS in myofibroblasts promotes kidney fibrosis, at least in part, via increased Bst2 expression. Thus, we have identified and demonstrated that OASIS signaling is a novel regulator of kidney fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available